Floatz logo

Therapeutic Asset Ratings

164 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Abbv-901
Ovarian Cancer
AbbVieP1C (36)
Azirkitug
Non-Small Cell Lung Carcinoma
AbbVieP1C (36)
Azirkitug
Pancreatic Neoplasm
AbbVieP1C (36)
Budigalimab
Colorectal Cancer
AbbVieP1C (36)
Telisotuzumab Adizutecan
Pancreatic Neoplasm
AbbVieP1C (36)
TIPIRACIL
Non-Small Cell Lung Carcinoma
AbbVieP1C (36)
Trifluridine
Non-Small Cell Lung Carcinoma
AbbVieP1C (36)
Lemzoparlimab
Plasma Cell Myeloma
AbbVieP1D (31)
Abbv-932
Bipolar Disorder
AbbVieP2NR (0)
Imgn151
Primary Peritoneal Carcinoma
AbbVieP2NR (0)
Telisotuzumab Adizutecan
Solid Tumors Harboring MET Amplification
AbbVieP2NR (0)
Abbv-400
Breast Cancer
AbbVieP1NR (0)
Abbv-932
Generalized Anxiety Disorder
AbbVieP1NR (0)
Azirkitug
Colorectal Cancer
AbbVieP1NR (0)
Showing 151 to 164 of 164 assets
PreviousPage 7 of 7Next